Array Technologies, Inc. (ARRY) Downgraded Amid Global Tariff Concerns
Array Technologies, Inc. (NASDAQ:ARRY) is among the most undervalued solar stocks to buy now. Analysts at BofA have downgraded Array Technologies, Inc.
Insider Monkey Blog
AQR Capital Expands Enphase Energy, Inc. (ENPH) Holdings to 0.53%
Enphase Energy, Inc. (NASDAQ:ENPH) is among the most undervalued solar stocks to buy now. AQR Capital Management LLC expanded its holdings in Enphase Energy, Inc.
Origami Solar Deal Boosts Nextracker Inc. (NXT) Outlook, UBS Says ‘Buy’
Nextracker Inc. (NASDAQ:NXT) is among the most undervalued solar stocks to buy now. Jon Windham, an analyst at UBS, reaffirmed a ‘Buy’ rating on Nextracker Inc.
AbbVie (ABBV)’s Dividend Track Record: How It Became a Leader in Consistent Dividends
AbbVie Inc. (NYSE:ABBV) is an Illinois-based pharmaceutical company. It has delivered strong results in 2025, easily beating the broader market.
Optimize Financial Raises First Solar, Inc. (FSLR) Stake by 76.7%
First Solar, Inc. (NASDAQ:FSLR) is among the most undervalued solar stocks to buy now. According to the recent disclosure with the SEC, Optimize Financial Inc.
Alyeska Boosts Crescent Energy Company (CRGY) Stake to 0.62% Following Vital Energy Deal
Crescent Energy Company (NYSE:CRGY) is among the best stocks with the highest upside potential. During the first quarter, Alyeska Investment Group L.P.
Raymond James Raises Mach Natural Resources LP (MNR) Investment
Mach Natural Resources LP (NYSE:MNR) is among the best stocks with the highest upside potential. In the first quarter, Raymond James Financial Inc.
Qfin Holdings, Inc. (QFIN) Sees Stake Increase as Business Model Drives Market Share
Qfin Holdings, Inc. (NASDAQ:QFIN) is among the best stocks with the highest upside potential.
Procter & Gamble’s Legacy of Consistent Dividends: Over Six Decades of Reliability
The Procter & Gamble Company (NYSE:PG) isn’t usually a top pick for growth-focused investors, but it has long been a favorite among those looking for steady income.
New Study Results Highlight BioMarin’s VOXZOGO Efficacy in Children
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the best stocks with the highest upside potential.
BitFuFu Strengthens Position in Bitcoin with Improved Fleet Performance
BitFuFu Inc. (NASDAQ:FUFU) is among the best stocks with the highest upside potential. During August, BitFuFu Inc.
Mirae Asset Expands Vista Energy, S.A.B. de C.V. (VIST) Position to 896,300 Shares
Vista Energy, S.A.B. de C.V. (NYSE:VIST) is among the best stocks with the highest upside potential. Mirae Asset Global ETFs Holdings Ltd.
Nomura Boosts LexinFintech Holdings Ltd. (LX) Stake by 437.7%
LexinFintech Holdings Ltd. (NASDAQ:LX) is among the best stocks with the highest upside potential.
PDT Partners Reduces Position in Riley Exploration Permian, Inc. (REPX) to 0.08%
Riley Exploration Permian, Inc. (NYSEAMERICAN:REPX) is among the best stocks with the highest upside potential.
Why Exxon Mobil (XOM) Remains a Top Pick for Consistent Dividends in the Energy Sector
Exxon Mobil Corporation (NYSE:XOM), an American oil giant, has gained only about 5% so far this year.
Telix Pharmaceuticals Begins Phase 3 Trial for Prostate Cancer Diagnostics
Telix Pharmaceuticals Limited (NASDAQ:TLX) is among the best stocks with the highest upside potential.
Guggenheim Sets $8 Price Target as Black Diamond Therapeutics, Inc. (BDTX) Prepares Phase 2 Results
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is among the best stocks with the highest upside potential. Guggenheim assumed coverage on Black Diamond Therapeutics, Inc.
13 Most Oversold Healthcare Stocks So Far in 2025
The healthcare innovation landscape in 2025 is navigating a complex mix of challenges and opportunities, marked by contrasting trends in fundraising, investment, and technology...
Roblox Corporation (RBLX) Surged in Q2. Here’s Why
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter.
Sands Capital Global Growth Strategy’s Q2 2025 Investor Letter
Sands Capital, an investment management company, released its “Sands Capital Global Growth Fund” second-quarter 2025 investor letter.
Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic Hepatitis
Bausch Health Companies Inc.
Jazz Pharmaceuticals plc (JAZZ) Wins FDA Nod for Modeyso in Rare Pediatric Brain Tumors
Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharmaceutical leader, develops and commercializes therapies for complex conditions in oncology, neuroscience, and sleep medicine...
Here’s What Makes Cloudflare (NET) Worth Holding Long-Term
Sands Capital, an investment management company, released its “Sands Capital Global Growth Strategy” second-quarter 2025 investor letter.
Perrigo Company plc (PRGO) Sells Dermacosmetics Unit in €327M Deal
Perrigo Company plc (NYSE:PRGO), a global healthcare supplier, specializes in over-the-counter (OTC) and self-care products, generic prescription pharmaceuticals, and active pharmaceutical...
Royalty Pharma plc (RPRX) Reports 20% Portfolio Growth, Posts $727M in Q2 Receipts
Royalty Pharma plc (NASDAQ:RPRX), a biopharmaceutical company specializing in acquiring and managing royalties from marketed drugs, continues to demonstrate strong growth and ...
Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction
Bristol-Myers Squibb Company (NYSE:BMY), a global biopharmaceutical leader, specializes in oncology, immunology, cardiovascular, hematology, and neuroscience therapies, with blockbuster...
Visa (V) Fell Amid a Broader Selloff in The Card Network
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter.
Teva Pharmaceutical Industries Limited (TEVA)’s Emrusolmin Gains FDA Fast Track for Multiple System Atrophy
Teva Pharmaceutical Industries Limited (NYSE:TEVA), a global pharmaceutical company, continues its transition from a generics-focused firm to a biopharmaceutical leader.
Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)’s 2025–2026 COVID-19 Vaccine
Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to advance innovative medicines and vaccines across oncology, immunology, rare diseases, and more.
Universal Health Services, Inc. (UHS) Q2 Revenue Climbs Nearly 10% on Medicaid Boosts
Universal Health Services, Inc.
Teleflex Incorporated (TFX) Plans 2026 Split into Two Independent Companies
Teleflex Incorporated (NYSE:TFX) tops our list for being one of the cheap healthcare stocks.
Here’s Sands Capital Select Growth Strategy’s Views on Shopify (SHOP)
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter.
Increased Customer Confidence Boosted Broadcom (AVGO) in Q2
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter.
Is Ultragenyx Pharmaceutical (RARE) a Compelling Long-Term Opportunity?
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter.
Is Arthur J. Gallagher (AJG) Positioned for Long-Term Growth?
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter.
Sands Capital Select Growth Strategy Sold Uber Technologies (UBER) due to Heightened Uncertainty
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter.
What Makes Carvana (CVNA) an Investment Bet?
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter.
Sands Capital Select Growth Strategy Q2 2025 Investor Letter
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q2 2025 investor letter. U.S.
Here’s Why Carvana’s (CVNA) Management Reiterated Their Outlook
Optimist Fund, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Wayfair (W): The Tide Is Finally Turning
Optimist Fund, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
7 Stocks That Could 10X in the Next 3 Years
On September 15, Tom Lee, the head of research at Fundstrat Global Advisors, appeared on a CNBC interview to share his insights ahead of the rate cut decision.
Revolve (RVLV) Declined Due to Management’s Comments
Optimist Fund, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Infinity Natural Resources (INR) Fell This Week. Here is Why.
The share price of Infinity Natural Resources, Inc.
enCore Energy (EU): Among the Energy Stocks that Fell This Week
enCore Energy Corp. (NASDAQ:EU) announced a significant leadership change last week, appointing Kevin Kremke as Chief Financial Officer effective October 1, 2025. Mr.
Here is Why Kodiak Gas Services (KGS) Fell Recently
The share price of Kodiak Gas Services, Inc.
Here is Why Cactus (WHD) Fell Recently
Cactus, Inc. (NYSE:WHD) faced downward pressure after it was revealed last week that William D.
Delek US Holdings (DK) Falls After a Strong Rally
The share price of Delek US Holdings, Inc.
Hedge Fund Resource Center
